Showing results (41-50 of 683) with videos related to
Sort By:
Pageof 69
Clinical Nephrology|October 1, 1992
Severe hemorrhagic complications from infection with nephropathia epidemica strain of HantavirusM Zeier, L Zöller, T Weinreich, et al.Clinical Nephrology|December 24, 1997
Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppressionE Allmaras, R Nowack, K Andrassy, et al.Clinical Nephrology|October 30, 2009
Optimal blood pressure control versus additional immunosuppressive therapy in idiopathic membranous nephropathy - a retrospective analysisR Dikow, P Quentmeier, V Schwenger, et al.Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Effect of vaccination schedule and dialysis on hepatitis B vaccination response in uraemic patientsJ Bommer, E Ritz, K Andrassy, et al.Deutsche Medizinische Wochenschrift (1946)|January 28, 1983
[Mesangial IgA-glomerulonephritis]M Rambausek, H P Seelig, K Andrassy, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1996
Antibodies to neutrophil elastase: a study in patients with vasculitisS Apenberg, K Andrassy, I Wörner, et al.Kidney International|November 1, 1995
PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritisZ I Niemir, H Stein, I L Noronha, et al.Annales De Medecine Interne|July 7, 1999
Clinical features and natural history of IgA nephropathyI Rychlik, K Andrassy, R Waldherr, et al.Klinische Wochenschrift|January 15, 1980
Stauffer's syndrome in renal cell carcinoma evidence for intravascular coagulationK Andrassy, H Gärtner, W H Siede, et al.Diagnostic Microbiology and Infectious Disease|May 1, 1995
Pharmacokinetics of cefotaxime in dialysis patientsK AndrassyPageof 69